Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05207878
Other study ID # 202009183
Secondary ID R01NS114046-01A1
Status Recruiting
Phase N/A
First received
Last updated
Start date December 9, 2021
Est. completion date December 2025

Study information

Verified date April 2024
Source Washington University School of Medicine
Contact Benjamin A Philip, PhD
Phone ?(314) 286-1634?
Email bphilip@wustl.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to determine which parts of the brain make it possible for some people to move skillfully with their left non-dominant hand.


Description:

This is a one-visit study, in which right-handed participants (individuals with unilateral peripheral nerve injury to the right upper limb, and healthy controls) will complete surveys and perform movement tasks. Movement tasks will be performed inside and outside a magnetic resonance imaging (MRI) scanner. Some participants will also receive transcranial magnetic stimulation (TMS) to briefly interfere with these putative brain networks.


Recruitment information / eligibility

Status Recruiting
Enrollment 147
Est. completion date December 2025
Est. primary completion date December 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility This study contains two groups: typical controls and patients. Participants will be matched by age and sex between the two groups. No randomization will occur. A. Inclusion criteria (all participants): 1. Age = 18 2. English speaking and reading 3. Able to fit in Prisma scanner bore (60 cm diameter) 4. Right hand dominant (self report, and Edinburgh handedness = +40) B. Inclusion criteria (patients only): 1. Chronic unilateral upper extremity peripheral nerve injury to the right side - "Chronic" defined as = 6 months since injury - "Upper extremity" defined as hand, arm, or shoulder (including e.g. brachial plexus) - "Injury" defined as localized cause (e.g. mechanical/tumor, not distributed pathology), including compression 2. Some impairment to writing, requiring both of: - Difficulty writing, as determined by score 2+ (Mild+) on "How much difficulty have you had in the last week with writing?" (From Disabilities of the Arm, Shoulder, and Hand survey question #2) - Box and Blocks motor performance =1 standard deviation below the mean of age-matched healthy adults (Mathiowetz et al. 1985, AJOT). C. Exclusion criteria (all participants) 1. Currently intoxicated or otherwise non-compliant 2. Chronic pain diagnosis unrelated to the nerve injury 3. Uncorrected visual impairment that interferes with ability to see drawings in MRI 4. Motor function diagnoses that affect function of the left hand, now or in past 2 years 5. Motor function diagnoses currently affecting the right hand, unrelated to the nerve injury - This is not meant to exclude a single event with complex consequences (e.g. nerve and tendon) - This is not meant to exclude multiple nerve injuries in the same arm, if each one is eligible (II.B.1) - This is meant to exclude e.g. injury and unrelated musculoskeletal disorder in same arm 6. Upper extremity surgery, including peripheral nerve surgery, within last 2 months 7. Contraindication for MRI 8. Contraindication for transcranial magnetic stimulation (TMS) - May exclude from TMS only (since not all participants undergo TMS), or exclude from full study 9. Amputation affecting any part of thumb, index, or middle fingers (including higher level, e.g. whole hand) 10. History of chronic cocaine use (based on medical record or volunteered; will not actively inquire) 11. Diagnosis of schizophrenia or other rare psychiatric disorder - This is not meant to exclude depression or anxiety 12. History of major neurological diagnosis, e.g. stroke, traumatic brain injury, Alzheimer's, Parkinson's - This is not meant to exclude concussion UNLESS < 6 months ago, or post-concussion syndrome (diagnosed or self-report) D. Exclusion criteria (controls only) 1. Motor function diagnoses that affect function of either hand, now or in past 2 years

Study Design


Related Conditions & MeSH terms


Intervention

Other:
STEGA-MRI
Precision drawing task (movement assessment)

Locations

Country Name City State
United States Washington University School of Medicine Saint Louis Missouri

Sponsors (2)

Lead Sponsor Collaborator
Washington University School of Medicine National Institute of Neurological Disorders and Stroke (NINDS)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary BOLD (blood oxygen level dependent) signal in ROIs (regions of interest) BOLD signal in key ROIs (primary motor and posterior parietal cortex). ROI selection may be revisited after preliminary data review (35 participants) Day 1
Secondary Drawing smoothness Velocity smoothness in STEGA-MRI (Standardized Tracing Evaluation and Grapheme Assessment - MRI version) task Day 1
Secondary Hand choice Percentage of grasps made with right hand Day 1
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1